American International Group, Inc. Talis Biomedical Corp Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $5,957 - $10,591	-7,355 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $418 - $1,349	-322 Reduced 4.19%	7,355 $10,000
Q4 2021 Feb 11, 2022	SELL	$3.81 - $6.17 $876 - $1,419	-230 Reduced 2.91%	7,677 $31,000
Q3 2021 Nov 12, 2021	SELL	$6.02 - $12.46 $1,131 - $2,342	-188 Reduced 2.32%	7,907 $49,000
Q2 2021 Aug 13, 2021	BUY	$9.62 - $14.56 $3,655 - $5,532	380 Added 4.93%	8,095 $89,000
Q1 2021 May 07, 2021	BUY	$11.2 - $27.8 $86,408 - $214,477	7,715 New	7,715 $99,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.